Sarepta Therapeutics, Inc. SRPT
1,000 filings, 4 in the last 30 days
SEC filing indexWhat the 8-Ks said
4 events in the last 3 years: the officer, auditor, restatement, cyber, restructuring, listing, impairment and debt items. One line each, the filing's own words.
- Jul 27, 2026 CEO, CFO, COO or CAOCEO change “(the “Company”) appointed Michael Severino, M.D. as Chief Executive Officer of the Company, effective July 28, 2026 (the “Effective Date”).” 8-K item 5.02 · all documents
- Feb 25, 2026 CEO, CFO, COO or CAOCEO change “(the “Company”) of his decision to retire as Chief Executive Officer by the end of 2026 or upon the appointment of his replacement.” 8-K item 5.02 · all documents
- Jul 16, 2025 CEO, CFO, COO or CAOCOO change “On July 14, 2025, the Board appointed Ian Estepan as the Company’s President and Chief Operating Officer, Louise Rodino-Klapac, Ph.” 8-K item 5.02 · all documents
- Jul 16, 2025 RestructuringReported exit or disposal costs from a restructuring “. Costs Associated with Exit or Disposal Activities. Following an evaluation of its annual combined research and development and selling, general and administrative spend, the Company is undertaking a restructuring that includes a revised cost structure and program portfolio. In connection with those plans, on July 14, 2025, the Board of Directors of the Company (the “Board”) approved a reduction…” 8-K item 2.05 · all documents
From the SEC filing index and the text of each 8-K. A line appears only when the 8-K names one of these items; for item 5.02 only a move of the CEO, CFO, COO or chief accounting officer. Older 8-Ks may have no text downloaded, so they show no quote.
Late filings, 8-K notices and going concern
None found in the last 2 years
-
Late filing notices (NT 10-K, NT 10-Q)No notice in the last 2 years.
-
8-K notices: listing, impairment, debt triggerNo item 3.01, 2.06 or 2.04 in the last 2 years.
-
Going-concern language in the 10-KNo statement of substantial doubt in the latest 10-K.
Facts to read in the filing, not a verdict: many companies with one of these carry on normally, and a company with neither can still have problems.
Every filing on one line
Each mark is a filing or an event in one; the bigger square is a 10-K. Hover for what it is, click to open it.
All 36 events
- Nov 5, 2026 8-K Quarterly results8-K item 2.02
- Nov 5, 2026 10-Q Quarterly report (10-Q)period ended Sep 30, 2026
- Sep 23, 2026 8-K Material agreement signed8-K item 1.01
- Aug 5, 2026 8-K Quarterly results8-K item 2.02
- Aug 5, 2026 10-Q Quarterly report (10-Q)period ended Jun 30, 2026
- Jul 27, 2026 Officer CEO change(the “Company”) appointed Michael Severino, M.D. as Chief Executive Officer of the Company, effective July 28, 2026 (the “Effective Date”).
- Jun 4, 2026 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- May 6, 2026 8-K Quarterly results8-K item 2.02
- May 6, 2026 10-Q Quarterly report (10-Q)period ended Mar 31, 2026
- Mar 12, 2026 Planned sale STEPHEN MAYO (Director) gave notice of a planned sale of 7,239 shares worth about $123KForm 144, approximate sale date Mar 12, 2026
- Mar 2, 2026 Planned sale Cristin L. Rothfuss adopted a 10b5-1 trading planreported in the 10-K, up to 2,152 shares, runs to Jan 8, 2027
- Mar 2, 2026 10-K Annual report (10-K)period ended Dec 31, 2025
- Feb 25, 2026 Officer CEO change(the “Company”) of his decision to retire as Chief Executive Officer by the end of 2026 or upon the appointment of his replacement.
- Feb 25, 2026 8-K Quarterly results8-K item 2.02
- Jan 12, 2026 8-K Quarterly results8-K item 2.02
- Dec 19, 2025 8-K Material agreement signed, New debt or obligation8-K items 1.01, 2.03
- Dec 16, 2025 Planned sale IAN M ESTEPAN (Officer) gave notice of a planned sale of 13,187 shares worth about $294KForm 144, approximate sale date Dec 16, 2025
- Dec 11, 2025 8-K Unregistered share sale, Other events8-K items 3.02, 8.01
- Dec 8, 2025 8-K Director or officer change8-K item 5.02
- Nov 6, 2025 10-Q Quarterly report (10-Q)period ended Sep 30, 2025
- Nov 3, 2025 8-K Quarterly results8-K item 2.02
- Aug 29, 2025 8-K Material agreement signed, New debt or obligation, Other events8-K items 1.01, 2.03, 8.01
- Aug 21, 2025 8-K Unregistered share sale8-K item 3.02
- Aug 13, 2025 8-K Director or officer change8-K item 5.02
- Aug 6, 2025 10-Q Quarterly report (10-Q)period ended Jun 30, 2025
- Jul 21, 2025 8-K Other events8-K item 8.01
- Jul 16, 2025 Officer COO changeOn July 14, 2025, the Board appointed Ian Estepan as the Company’s President and Chief Operating Officer, Louise Rodino-Klapac, Ph.
- Jun 6, 2025 8-K Director or officer change, Shareholder vote results8-K items 5.02, 5.07
- May 6, 2025 10-Q Quarterly report (10-Q)period ended Mar 31, 2025
- Mar 3, 2025 Offering Shelf registration: shares and other securities, amount not fixedS-3ASR · from time to time offer, in one or more classes or series, separately or together, and in amounts, at prices and on terms to be set forth in one or more supplements to this prospectus, common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock or debt securiti
- Feb 28, 2025 Planned sale Michael A. Chambers adopted a 10b5-1 trading planreported in the 10-K, up to 88,286 shares, runs to Sep 12, 2025
- Feb 28, 2025 10-K Annual report (10-K)period ended Dec 31, 2024
- Feb 26, 2025 8-K Quarterly results8-K item 2.02
- Feb 14, 2025 8-K Material agreement signed, New debt or obligation8-K items 1.01, 2.03
- Jan 13, 2025 8-K Quarterly results8-K item 2.02
- Nov 26, 2024 8-K Material agreement signed8-K item 1.01
From the SEC filing index. Insider purchases go back 180 days (the Form 4s downloaded).
Every filing
Newest first, by kind · each form links to sec.gov
| Filed | Form | What it is |
|---|---|---|
| Nov 13, 2026 | 13F-HR | |
| Nov 13, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 5, 2026 | 8-K | Quarterly results |
| Nov 5, 2026 | 10-Q | Quarterly report |
| Sep 23, 2026 | 8-K | Material agreement signed |
| Sep 8, 2026 | 4 | Insider trade |
| Sep 8, 2026 | 4 | Insider trade |
| Sep 8, 2026 | 4 | Insider trade |
| Sep 8, 2026 | 4 | Insider trade |
| Aug 14, 2026 | 13F-HR | |
| Aug 13, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Aug 5, 2026 | 8-K | Quarterly results |
| Aug 5, 2026 | 10-Q | Quarterly report |
| Jul 31, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jul 30, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jul 29, 2026 | 4 | Insider trade |
| Jul 29, 2026 | 3 | New insider |
| Jul 28, 2026 | S-8 | Shares registered for employee plans |
| Jul 27, 2026 | 8-K | Director or officer change, Regulation FD disclosure |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 5, 2026 | 4 | Insider trade |
| Jun 4, 2026 | S-8 | Shares registered for employee plans |
| Jun 4, 2026 | 8-K | Director or officer change, Shareholder vote results |
| May 13, 2026 | 13F-HR | |
| May 6, 2026 | 8-K | Quarterly results |
| May 6, 2026 | 10-Q | Quarterly report |
| Apr 30, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 29, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Apr 24, 2026 | ARS | Annual report to shareholders |
| Apr 24, 2026 | DEFA14A | Extra proxy material |
| Apr 24, 2026 | DEF 14A | Proxy statement |
| Mar 27, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Mar 13, 2026 | 4 | Insider trade |
| Mar 13, 2026 | 4 | Insider trade |
| Mar 13, 2026 | 4 | Insider trade |
| Mar 13, 2026 | 4 | Insider trade |
| Mar 13, 2026 | 4 | Insider trade |
| Mar 12, 2026 | 144 | Notice of planned insider sale |
| Mar 11, 2026 | 4 | Insider trade |
| Mar 11, 2026 | 4 | Insider trade |
| Mar 11, 2026 | 4 | Insider trade |
| Mar 11, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 3, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 4 | Insider trade |
| Mar 2, 2026 | 10-K | Annual report |
| Feb 27, 2026 | 4 | Insider trade |
| Feb 27, 2026 | 4 | Insider trade |
| Feb 25, 2026 | 8-K | Director or officer change |
| Feb 25, 2026 | 8-K | Quarterly results |
| Feb 13, 2026 | 13F-HR | |
| Feb 13, 2026 | SCHEDULE 13G | 5%+ owner (passive) |
| Jan 29, 2026 | 4 | Insider trade |
| Jan 29, 2026 | 4 | Insider trade |
| Jan 21, 2026 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jan 12, 2026 | 8-K | Quarterly results |
| Dec 19, 2025 | 4 | Insider trade |
| Dec 19, 2025 | 8-K | Material agreement signed, New debt or obligation |
| Dec 18, 2025 | 4 | Insider trade |
| Dec 16, 2025 | 144 | Notice of planned insider sale |
| Dec 11, 2025 | 8-K | Unregistered share sale, Other events |
| Dec 10, 2025 | 4 | Insider trade |
| Dec 9, 2025 | 4 | Insider trade |
| Dec 8, 2025 | 8-K | Director or officer change |
| Dec 2, 2025 | 4 | Insider trade |
| Nov 19, 2025 | 4 | Insider trade |
| Nov 14, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Nov 6, 2025 | 10-Q | Quarterly report |
| Nov 3, 2025 | 8-K | Quarterly results |
| Sep 8, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Sep 5, 2025 | 4 | Insider trade |
| Sep 5, 2025 | 4 | Insider trade |
| Sep 5, 2025 | 4 | Insider trade |
| Sep 5, 2025 | 4 | Insider trade |
| Aug 29, 2025 | 8-K | Material agreement signed, New debt or obligation, Other events |
| Aug 21, 2025 | 8-K | Unregistered share sale |
| Aug 15, 2025 | SCHEDULE 13D/A | 5%+ owner (active), amended |
| Aug 13, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Aug 13, 2025 | 8-K | Director or officer change |
| Aug 13, 2025 | 144 | Notice of planned insider sale |
| Aug 6, 2025 | S-8 | Shares registered for employee plans |
| Aug 6, 2025 | 4 | Insider trade |
| Aug 6, 2025 | 4 | Insider trade |
| Aug 6, 2025 | 4 | Insider trade |
| Aug 6, 2025 | 10-Q | Quarterly report |
| Aug 4, 2025 | 4 | Insider trade |
| Aug 4, 2025 | 3 | New insider |
| Jul 25, 2025 | SCHEDULE 13G/A | 5%+ owner (passive), amended |
| Jul 25, 2025 | SCHEDULE 13G | 5%+ owner (passive) |
| Jul 21, 2025 | 8-K | Other events |
| Jul 16, 2025 | 8-K | Quarterly results, Restructuring or exit costs, Director or officer change |
| Jun 6, 2025 | 8-K | Director or officer change, Shareholder vote results |
Show the other 75 filings on this page
Press releases with quarterly results are attached to the 8-Ks marked "Quarterly results"; read them on Earnings releases.
Sources
SEC's filing index (data.sec.gov submissions). Each form links to the document on sec.gov.
Also
Earnings releases: the text of each quarter's results release. Statements by period: the income statement, balance sheet or cash flow of the last filings side by side.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/SRPT/export.csv") into a cell.